非小细胞肺癌疫苗的研究现状及进展

Situation and advances of vaccines for non-small cell lung cancer

在世界范周内，肺癌已占所有癌症病死率的首位，十分迫切地需要新的治疗方法。肿瘤疫苗代表了一种低毒、高特异性的新治疗方法，作为一种极具发展前景的治疗方式有望为肺癌的治疗带来新的希望。近年来，越来越多的临床研究结果表明，免疫治疗应用于肺癌可以获得显著的临床疗效。本文就非小细胞肺癌的疫苗的研究现状及进展作一综述。

Since lung cancer is the leading cause of the cancer-associated death, new curative treatments are always desired in the clinic, Owing to its low toxicity and high specificity, tumor vaccines are gradually drawing people＇s attention as a new therapy providing lung cancer treatment a great prospect. Recently, increased evidence from clinical studies revealed that vaccines for lung cancer demonstrated a prominent clinical effect. This review aims to summarize the current situation and progression for the vaccines for non small cell lung cancer （NSCLC） patients.